EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Multimodal, Longitudinal Profiling of SCA1 Identifies Predictors of Disease Severity and Progression

Teije H van Prooije iD, Kirsten C J Kapteijns iD, Jack J A van Asten iD, Joanna IntHout iD, Marcel M Verbeek iD, Tom W J Scheenen iD, Bart P van de Warrenburg iD

Annals of Neurology · 2024

DOI: 10.1002/ana.27032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2024. Verfasst von Teije H van Prooije und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, Netherlands. Hauptthemen laut MEDLINE: Disease Progression, Spinocerebellar Ataxias, Severity of Illness Index, Biomarkers. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Spinocerebellar ataxia type 1 (SCA1) is a rare autosomal dominant neurodegenerative disease. Objective surrogate markers sensitive to detect changes in disease severity are needed to reduce sample sizes in interventional trials and identification of predictors of faster disease progression would facilitate patient selection, enrichment, or stratification in such trials.

Methods

We performed a prospective 1‐year longitudinal, multimodal study in 34 ataxic SCA1 individuals and 21 healthy controls. We collected clinical, patient‐reported outcomes, biochemical and magnetic resonance (MR) biomarkers at baseline and after 1 year. We determined 1‐year progression and evaluated the potential predictive value of several baseline markers on 1‐year disease progression.

Results

At baseline, multiple structural and spectroscopic MR markers in pons and cerebellum differentiated SCA1 from healthy controls and correlated with disease severity. Plasma and cerebrospinal fluid (CSF) neurofilament light (NfL) chain and CSF glial fibrillary acidic protein (GFAP) were elevated in SCA1. In longitudinal analysis, total brainstem and pontine volume change, inventory of non‐ataxia signs (INAS) count, and SCA functional index (SCAFI) showed larger responsiveness compared to the Scale for Assessment and Rating of Ataxia (SARA). Longer disease duration, longer non‐expanded CAG repeat length, and higher disease burden were associated with faster SARA increase after 1‐year in the SCA1 group. Similarly, lower baseline brainstem, pontine, and cerebellar volumes, as well as lower levels of N‐acetylaspartate and glutamate in the cerebellar white matter, were also associated with faster SARA increase.

Interpretation

Our results guide the selection of the most sensitive measures of disease progression in SCA1 and have identified features associated with accelerated progression that could inform the design of clinical trials. ANN NEUROL 2024;96:774–787

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease ProgressionSpinocerebellar AtaxiasSeverity of Illness IndexBiomarkersHumansMaleFemaleLongitudinal StudiesMiddle AgedAdultCerebellumProspective StudiesMagnetic Resonance ImagingPonsAgedNeurofilament ProteinsGlial Fibrillary Acidic Protein

Substanzen

BiomarkersNeurofilament ProteinsGlial Fibrillary Acidic Proteinneurofilament protein L

Autor:innen und Institutionen

  • Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, Netherlands.
  • Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Netherlands.
  • Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands.
  • Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.

ORCID-Profile: Teije H van Prooije, Kirsten C J Kapteijns, Jack J A van Asten, Joanna IntHout, Marcel M Verbeek, Tom W J Scheenen, Bart P van de Warrenburg

Förderung

  • ZonMw

Zitieren

APA

van Prooije, T. H., Kapteijns, K. C. J., van Asten, J. J. A., IntHout, J., Verbeek, M. M., Scheenen, T. W. J., & van de Warrenburg, B. P. (2024). Multimodal, Longitudinal Profiling of SCA1 Identifies Predictors of Disease Severity and Progression. Annals of Neurology. https://doi.org/10.1002/ana.27032

Vancouver

van Prooije TH, Kapteijns KCJ, van Asten JJA, IntHout J, Verbeek MM, Scheenen TWJ, et al. Multimodal, Longitudinal Profiling of SCA1 Identifies Predictors of Disease Severity and Progression. Annals of Neurology. 2024. doi:10.1002/ana.27032

BibTeX
@article{vanProoije2024,
  author = {van Prooije, Teije H and Kapteijns, Kirsten C J and van Asten, Jack J A and IntHout, Joanna and Verbeek, Marcel M and Scheenen, Tom W J and van de Warrenburg, Bart P},
  title = {Multimodal, Longitudinal Profiling of SCA1 Identifies Predictors of Disease Severity and Progression},
  journal = {Annals of Neurology},
  year = {2024},
  doi = {10.1002/ana.27032}
}
Kostenlos starten →